Found 1255 clinical trials
Study to Assess the Efficacy Safety and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) (AERIFY-2)
-severe COPD exacerbations in former smokers with moderate-to-severe COPD Secondary Objectives: Primary population (former smokers cohort):
- 662 views
- 27 Sep, 2022
- 58 locations
SEVERE COPD?
North Carolina Clinical Research is enrolling adults 40+ living with severe to very severe COPD fora clinical research study comparing two approved medications.
- 5 views
- 10 Jan, 2022
- 1 location
COPD Exacerbation Research Study
Looking for patients at least 40 years of age who have been diagnosed with COPD and recently had several events of worsening of symptoms.
- 133 views
- 23 Nov, 2020
- 1 location
DO YOU HAVE COPD?
You may be eligible to participate in a research study of an investigational new medication.
- 0 views
- 29 Jun, 2022
- 1 location
Add on treatment for COPD for patients who experience frequent exacerbations
Current or former smokers who are diagnosed with COPD and experienced at least 2 exacerbations- worsening of symptoms requiring steroid treatment or hospitalization despite being on multiple
- 0 views
- 09 Jun, 2022
- 1 location
A Phase III Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine over 24 Weeks in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease.
This study will enroll approximately 800 patients with moderate to severe COPD in 2 subsets. The 24-week subset will enroll approximately 400 patients randomized 1:1 ensifentrine (3 mg
- 183 views
- 23 Nov, 2020
- 1 location
NO 0050-0637
ICON Early Phase Services is conducting a non-interventional device research study adults age 40+ who are either healthy, or, have chronic obstructive pulmonary disease (COPD). This study is being
- 613 views
- 23 Nov, 2020
- 1 location
COPD Research Study for those with currently using inhaled medications (triple therapy) and have required an oral steroid for a flare in breathing 1-2 times in the last 12 months.
This investigational study is enrolling moderate to severe COPD subjects. To qualify you must be on inhaled maintenance medications and have required oral steroids 1-2 times or
- 147 views
- 23 Nov, 2020
- 1 location
A 5 day course of an investigational antiviral tablet for those positive to RSV.
5 visits over 2 weeks testing an investigational medication for RSV. Must be between 18-75 years and experiencing cold and flu like symptoms.
- 120 views
- 23 Nov, 2020
- 1 location
RSV Vaccine
VOLUNTEERS NEEDED FOR AN RSV VACCINE STUDYOlder adults are more likely to develop serious complications from a cold-like virus called Respiratory Syncytial Virus (RSV). Join a clinical
- 19 views
- 03 Dec, 2021
- 1 location